Novartis Deal History & Licensing Activity

About Novartis Licensing & Deal Activity

Novartis is a large pharma company based in Switzerland that has been actively engaged in licensing transactions across the biopharma landscape. With 61 deals over the past three years, Novartis ranks among the most acquisitive companies tracked by Ambrosia Ventures.

Key therapeutic areas of focus for Novartis include Oncology (16 deals and trials), Rare Disease (14 deals and trials), Cardiovascular (12 deals and trials), and Solid Tumors (9 deals and trials). In terms of modality, Novartis has shown particular interest in other, small molecules, oligonucleotides.

Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Novartis and 850+ other biopharma companies. Use our Solidus to benchmark your asset against Novartis's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.